Related Experiment Video
Updated: Jul 18, 2026

08:53
In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
Published on: September 16, 2019
Tumour-host interactions: implications for developing anti-cancer therapies
Bedrick B Gadea1, Johanna A Joyce
1Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA.
Expert Reviews in Molecular Medicine
|December 13, 2006
Summary
Understanding how the local tumor environment influences cancer progression is key. This review explores targeting pro-tumorigenic functions of stromal cells while preserving their normal roles for better cancer treatment.
Area of Science:
- Oncology
- Cancer Biology
- Cellular Microenvironment
Background:
- Cancers develop through genetic and epigenetic alterations, including oncogene activation and tumor suppressor gene inactivation.
- The local host environment, particularly stromal cells, critically modulates cancer progression with context-dependent tumor-suppressive or promoting effects.
- Understanding the molecular interplay between cancer cells and stromal cells is crucial for developing targeted therapies.
Purpose of the Study:
- To review recent advancements in understanding the dual role of stromal cells in cancer development.
- To discuss strategies for selectively inhibiting pro-tumorigenic functions of stromal cells while maintaining their normal roles.
- To provide perspectives on translating discoveries from model systems to clinical applications.
Main Methods:
- Review of current literature on cancer biology and the tumor microenvironment.
- Analysis of molecular mechanisms underlying cancer cell-stromal cell interactions.
- Discussion of therapeutic strategies targeting stromal cell functions.
Main Results:
- Stromal cells exhibit context-dependent roles, acting as either tumor suppressors or promoters.
- Selective inhibition of pro-tumorigenic stromal cell functions is a promising therapeutic avenue.
- Understanding molecular modifications of normal cells by cancer cells is essential for targeted intervention.
Conclusions:
- Achieving a balance by preserving beneficial stromal cell functions and inhibiting detrimental ones is critical for cancer therapy.
- Further research into the molecular mechanisms of cancer-stromal cell communication is needed.
- Translational research holds promise for developing novel cancer treatments targeting the tumor microenvironment.
Related Concept Videos
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Hybridoma Technology
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...

